Novadaq Technologies Inc.  

(Public, NASDAQ:NVDQ)   Watch this stock  
Find more results for NVDQ
10.25
-0.11 (-1.06%)
Real-time:   12:19PM EDT
NASDAQ real-time data - Disclaimer
Currency in USD
Range 10.25 - 10.40
52 week 9.88 - 18.24
Open 10.32
Vol / Avg. 150,970.00/754,786.00
Mkt cap 581.85M
P/E     -
Div/yield     -
EPS -0.35
Shares 55.57M
Beta 0.90
Inst. own     -
Aug 4, 2015
Q2 2015 Novadaq Technologies Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 27, 2015
Novadaq Technologies Inc at Craig-Hallum Capital Group Institutional Investor Conference
May 21, 2015
Novadaq Technologies Inc Annual Shareholders Meeting (Estimated)
May 19, 2015
Novadaq Technologies Inc at UBS Global Healthcare Conference
May 14, 2015
Novadaq Technologies Inc at Bank of America Merrill Lynch Health Care Conference
May 13, 2015
Novadaq Technologies Inc Annual Shareholders Meeting
May 4, 2015
Novadaq Technologies Inc at Bloom Burton & Co Healthcare Investor Conference
Apr 28, 2015
Q1 2015 Novadaq Technologies Inc Earnings Call
Apr 28, 2015
Q1 2015 Novadaq Technologies Inc Earnings Release
Mar 12, 2015
Novadaq Technologies Inc at Barclays Healthcare Conference - Webcast
More events from DailyFinance »    

Address

5090 Explorer Dr Suite 202
MISSISSAUGA, ON L4W 4T9
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Novadaq Technologies Inc. primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's imaging platform can be used to visualize blood vessels, nerves and the lymphatic system during surgical procedures. The Company’s SPY, SPY Elite, LUNA and PINPOINT Imaging Systems are based upon the Company’s core SPY fluorescence technology. The Company manufactures and markets Heart Laser System [TMR Laser System] for Transmyocardial Revascularization [TMR]. The Company′s SPY Imaging core technology platform provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels. PINPOINT provides surgeons with better visualization of important information related to anatomic structures and tissue perfusion during complex minimally invasive procedures.

Officers and directors

Arun Menawat President, Chief Executive Officer, Director
Bio & Compensation  - Reuters
Roger Deck Chief Financial Officer
Bio & Compensation  - Reuters
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Bio & Compensation  - Reuters
Patrice E. Merrin Director
Age: 66
Bio & Compensation  - Reuters
Robert S. White Director
Bio & Compensation  - Reuters
Aaron Davidson Independent Director
Age: 46
Bio & Compensation  - Reuters
Harold O. Koch Jr. Independent Director
Age: 59
Bio & Compensation  - Reuters